While SGLT2 inhibitors have demonstrated significant benefits across metabolic, cardiovascular, and renal pathways, no established guidelines currently recommend their routine use in CMS patients
This deck provides essential guidelines, research findings, and practical applications, empowering healthcare professionals to effectively implement GLP-1 treatments for enhanced patient outcomes and long-term weight management success
TRPM7, transient receptor potential cation channel, subfamily M, member 7
This powerful combination supports skin brightening, anti-aging, liver detoxification, and immune health with enhanced absorption and better results
Variant between CPT1B and CHKB associated with susceptibility to narcolepsy
You can rely on Paloma Health to help you manage your thyroid and GLP-1/GIP treatment together with more confidence